These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 29564582)

  • 1. Novel Mutation in CECR1 Leads to Deficiency of ADA2 with Associated Neutropenia.
    Cipe FE; Aydogmus C; Serwas NK; Keskindemirci G; Boztuğ K
    J Clin Immunol; 2018 Apr; 38(3):273-277. PubMed ID: 29564582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenosine Deaminase Two and Immunoglobulin M Accurately Differentiate Adult Sneddon's Syndrome of Unknown Cause.
    Santo GC; Baldeiras I; Guerreiro R; Ribeiro JA; Cunha R; Youngstein T; Nanthapisal S; Leitão J; Fernandes C; Caramelo F; Almeida MDR; Brás J; Santana I;
    Cerebrovasc Dis; 2018; 46(5-6):257-264. PubMed ID: 30645994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ADA2 deficiency (DADA2) as an unrecognised cause of early onset polyarteritis nodosa and stroke: a multicentre national study.
    Caorsi R; Penco F; Grossi A; Insalaco A; Omenetti A; Alessio M; Conti G; Marchetti F; Picco P; Tommasini A; Martino S; Malattia C; Gallizzi R; Podda RA; Salis A; Falcini F; Schena F; Garbarino F; Morreale A; Pardeo M; Ventrici C; Passarelli C; Zhou Q; Severino M; Gandolfo C; Damonte G; Martini A; Ravelli A; Aksentijevich I; Ceccherini I; Gattorno M
    Ann Rheum Dis; 2017 Oct; 76(10):1648-1656. PubMed ID: 28522451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Monogenic Disease with a Variety of Phenotypes: Deficiency of Adenosine Deaminase 2.
    Özen S; Batu ED; Taşkıran EZ; Özkara HA; Ünal Ş; Güleray N; Erden A; Karadağ Ö; Gümrük F; Çetin M; Sönmez HE; Bilginer Y; Ayvaz DÇ; Tezcan I
    J Rheumatol; 2020 Jan; 47(1):117-125. PubMed ID: 31043544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deficiency of Adenosine Deaminase 2 (DADA2): Updates on the Phenotype, Genetics, Pathogenesis, and Treatment.
    Meyts I; Aksentijevich I
    J Clin Immunol; 2018 Jul; 38(5):569-578. PubMed ID: 29951947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deficiency of Adenosine Deaminase Type 2: A Description of Phenotype and Genotype in Fifteen Cases.
    Nanthapisal S; Murphy C; Omoyinmi E; Hong Y; Standing A; Berg S; Ekelund M; Jolles S; Harper L; Youngstein T; Gilmour K; Klein NJ; Eleftheriou D; Brogan PA
    Arthritis Rheumatol; 2016 Sep; 68(9):2314-22. PubMed ID: 27059682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deficiency of Adenosine Deaminase 2 (DADA2), an Inherited Cause of Polyarteritis Nodosa and a Mimic of Other Systemic Rheumatologic Disorders.
    Hashem H; Kelly SJ; Ganson NJ; Hershfield MS
    Curr Rheumatol Rep; 2017 Oct; 19(11):70. PubMed ID: 28983775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monogenic polyarteritis: the lesson of ADA2 deficiency.
    Caorsi R; Penco F; Schena F; Gattorno M
    Pediatr Rheumatol Online J; 2016 Sep; 14(1):51. PubMed ID: 27609179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoimmune phenotype with type I interferon signature in two brothers with ADA2 deficiency carrying a novel CECR1 mutation.
    Skrabl-Baumgartner A; Plecko B; Schmidt WM; König N; Hershfield M; Gruber-Sedlmayr U; Lee-Kirsch MA
    Pediatr Rheumatol Online J; 2017 Aug; 15(1):67. PubMed ID: 28830446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early-onset stroke and vasculopathy associated with mutations in ADA2.
    Zhou Q; Yang D; Ombrello AK; Zavialov AV; Toro C; Zavialov AV; Stone DL; Chae JJ; Rosenzweig SD; Bishop K; Barron KS; Kuehn HS; Hoffmann P; Negro A; Tsai WL; Cowen EW; Pei W; Milner JD; Silvin C; Heller T; Chin DT; Patronas NJ; Barber JS; Lee CC; Wood GM; Ling A; Kelly SJ; Kleiner DE; Mullikin JC; Ganson NJ; Kong HH; Hambleton S; Candotti F; Quezado MM; Calvo KR; Alao H; Barham BK; Jones A; Meschia JF; Worrall BB; Kasner SE; Rich SS; Goldbach-Mansky R; Abinun M; Chalom E; Gotte AC; Punaro M; Pascual V; Verbsky JW; Torgerson TR; Singer NG; Gershon TR; Ozen S; Karadag O; Fleisher TA; Remmers EF; Burgess SM; Moir SL; Gadina M; Sood R; Hershfield MS; Boehm M; Kastner DL; Aksentijevich I
    N Engl J Med; 2014 Mar; 370(10):911-20. PubMed ID: 24552284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of Novel Adenosine Deaminase 2 Gene Variants and Varied Clinical Phenotype in Pediatric Vasculitis.
    Gibson KM; Morishita KA; Dancey P; Moorehead P; Drögemöller B; Han X; Graham J; Hancock REW; Foell D; Benseler S; Luqmani R; Yeung RSM; Shenoi S; Bohm M; Rosenberg AM; Ross CJ; Cabral DA; Brown KL;
    Arthritis Rheumatol; 2019 Oct; 71(10):1747-1755. PubMed ID: 31008556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two cases of ADA2 deficiency presenting as childhood polyarteritis nodosa: novel ADA2 variant, atypical CNS manifestations, and literature review.
    Ganhão S; Loureiro GB; Oliveira DR; Dos-Reis-Maia R; Aguiar F; Quental R; Moura C; Barreira JL; Rodrigues M; Brito I
    Clin Rheumatol; 2020 Dec; 39(12):3853-3860. PubMed ID: 32535845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new CECR1 mutation associated with severe hematological involvement in ADA2 deficiency.
    Nicoară D; Niță C; Stanilă A; Martiniuc A; Popa L; Petrescu E; Bătăneant M; Ciofu R; Guriță A; Tabăcaru R; Ionescu R; Groșeanu L
    Immun Inflamm Dis; 2023 Aug; 11(8):e930. PubMed ID: 37647436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel adenosine deaminase 2 mutations in a child with a fatal vasculopathy.
    Garg N; Kasapcopur O; Foster J; Barut K; Tekin A; Kızılkılıç O; Tekin M
    Eur J Pediatr; 2014 Jun; 173(6):827-30. PubMed ID: 24737293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deficiency of Adenosine Deaminase 2 Causes Antibody Deficiency.
    Schepp J; Bulashevska A; Mannhardt-Laakmann W; Cao H; Yang F; Seidl M; Kelly S; Hershfield M; Grimbacher B
    J Clin Immunol; 2016 Apr; 36(3):179-86. PubMed ID: 26922074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expanding spectrum of DADA2: a review of phenotypes, genetics, pathogenesis and treatment.
    Pinto B; Deo P; Sharma S; Syal A; Sharma A
    Clin Rheumatol; 2021 Oct; 40(10):3883-3896. PubMed ID: 33791889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening of 181 Patients With Antibody Deficiency for Deficiency of Adenosine Deaminase 2 Sheds New Light on the Disease in Adulthood.
    Schepp J; Proietti M; Frede N; Buchta M; Hübscher K; Rojas Restrepo J; Goldacker S; Warnatz K; Pachlopnik Schmid J; Duppenthaler A; Lougaris V; Uriarte I; Kelly S; Hershfield M; Grimbacher B
    Arthritis Rheumatol; 2017 Aug; 69(8):1689-1700. PubMed ID: 28493328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel ADA2 mutation presenting with neutropenia, lymphopenia and bone marrow failure in patients with deficiency in adenosine deaminase 2 (DADA2).
    Ghurye RR; Sundaram K; Smith F; Clark B; Simpson MA; Fairbanks L; Adhya Z; Mufti GJ; Marsh JCW; Ibrahim MAA
    Br J Haematol; 2019 Aug; 186(3):e60-e64. PubMed ID: 30924144
    [No Abstract]   [Full Text] [Related]  

  • 19. Novel Adenosine Deaminase 2 (ADA2) Mutations Associated With Hematological Manifestations.
    Albalawi R; Hanafy E; Alnafea H; Altowijiry M; Riyad S; Abufara F; Albolowi N
    J Investig Med High Impact Case Rep; 2021; 9():23247096211056770. PubMed ID: 34845942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis and management of ADA2 deficient polyarteritis nodosa.
    Human A; Pagnoux C
    Int J Rheum Dis; 2019 Jan; 22 Suppl 1():69-77. PubMed ID: 29624883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.